Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AIM ImmunoTech Inc. Common Stock
(NY:
AIM
)
0.1290
-0.0096 (-6.93%)
Official Closing Price
Updated: 8:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AIM ImmunoTech Inc. Common Stock
< Previous
1
2
3
4
5
Next >
AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
December 17, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card
December 16, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board Members
December 12, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Glass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. Mitchell
December 10, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Insights into AIM ImmunoTech's Upcoming Earnings
November 14, 2024
Via
Benzinga
Exploring AIM ImmunoTech's Earnings Expectations
November 07, 2024
Via
Benzinga
AIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024
May 16, 2024
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
ISS Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan and Dr. William M. Mitchell
December 05, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the Board
December 02, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Refutes Activist Group’s False and Misleading Claims
November 27, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Announces Cash Conservation Plan
November 27, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Preview: AIM ImmunoTech's Earnings
April 01, 2024
Via
Benzinga
Preview: AIM ImmunoTech's Earnings
November 14, 2023
Via
Benzinga
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
November 25, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Earnings Scheduled For November 15, 2024
November 15, 2024
Via
Benzinga
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
November 04, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via
Benzinga
AIM Stock Earnings: AIM ImmunoTech Beats EPS, Beats Revenue for Q2 2024
August 15, 2024
AIM stock results show that AIM ImmunoTech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
AIM Stock Earnings: AIM ImmunoTech Misses EPS, Beats Revenue for Q4 2023
April 02, 2024
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For April 2, 2024
April 02, 2024
Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.
Via
Benzinga
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
March 25, 2024
The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
February 12, 2024
Via
Benzinga
Earnings Scheduled For March 26, 2024
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 11, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 09, 2024
Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!
Via
InvestorPlace
AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting
January 05, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid
December 29, 2023
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Provides Update Regarding Annual Meeting
November 28, 2023
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying
November 28, 2023
The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.